GRIN1

GRIN1

Produktanfrage

Asset Licensing Opportunity
Resources

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
VIB-9600VIB-9600; MEDI-9600Phase 1 ClinicalMedimmune Llc, Viela Bio Inc, Horizon Therapeutics PLC
Autoimmune Diseases
Details
QLS-21908QLS-21908Phase 1 ClinicalQilu Pharmaceutical Co Ltd
Autoimmune Diseases
Details
Customer Reviews